Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Dichloromethane → N-[5-(2-furyl)-1,3,4-oxadiazol-2-yl]-8-methyl-2-(2-thienyl)-4-quinolinecarboxamide
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Dichloromethane | HCID 6344 | — |
| 반응물 | 5-(Furan-2-yl)-1,3,4-oxadiazol-2-amine | HCID 202185 | — |
| 반응물 | 8-Methyl-2-(thiophen-2-yl)quinoline-4-carboxylic acid | HCID 3604519 | — |
| 반응물 | Triphenylphosphine bromide | HCID 22470945 | — |
| 용매 | Pyridine | HCID 1049 | — |
| 생성물 | N-[5-(2-furyl)-1,3,4-oxadiazol-2-yl]-8-methyl-2-(2-thienyl)-4-quinolinecarboxamide | HCID 67204226 | 12.5% |
반응 단계
Triphenylphosphine bromide (352 mg, 0.80 mmol) was added to a methylene chloride (1 mL) solution of commercially available 8-methyl-2-(2-thienyl)-4-quinolinecarboxylic acid (108 mg, 0.40 mmol), and the mixture was stirred at room temperature for 1 hour. The reaction solution was added to a pyridine (3 mL) solution of 2-amino-5-(2-furyl)-1,3,4-oxadiazole (90.7 mg, 0.60 mmol), and the mixture was stirred at room temperature for 2 hours and then heated with stirring overnight at 60° C. The reaction solution was concentrated. After that, to the residue, water was added, and the deposited solid was collected by filtration, washed with water, dried, and then purified by preparative HPLC to obtain the title compound (22 mg, 0.05 mmol).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08466290B2 |
| 출처 데이터셋 | uspto-grants-2013_06 |
| ORD ID | ord-baaa908b98d24ca3bb60f5f72697d863 |
| 출처 메모 | uspto-grants-2013_06 |